Lynk Pharmaceuticals
A biotech company focusing on the discovery and development of novel medicines.
Launch date
Employees
Market cap
-
Enterprise valuation
$578m (Public information from Sep 2023)
Hangzhou Zhejiang (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
$20.0m | Seed | ||
$20.0m | Series A | ||
$50.0m | Series B | ||
* | $28.2m Valuation: $250m | Series C | |
* | CNY122m Valuation: CNY4.2b | Series C | |
| Total Funding | $135m | ||